Stratification issues with binary endpointsMEHROTRA, Devan V.Drug information journal. 2001, Vol 35, Num 4, pp 1343-1350, issn 0092-8615Article

Stratified experiments reexamined with emphasis on multicenter trialsJITENDRA GANJU; MEHROTRA, Devan V.Controlled clinical trials. 2003, Vol 24, Num 2, pp 167-181, issn 0197-2456, 15 p.Article

A More Powerful Average Bioequivalence Analysis for the 2 x 2 CrossoverSTEFANESCU, Catalina; MEHROTRA, Devan V.Communications in statistics. Simulation and computation. 2008, Vol 37, Num 1-2, pp 212-221, issn 0361-0918, 10 p.Article

Adaptive vs. group sequential self-designing trialsMEHROTRA, Devan V; XIAOYIN FAN.Biometrical journal. 2006, Vol 48, Num 4, pp 710-712, issn 0323-3847, 3 p.Article

Relative risk estimation and inference using a generalized logrank statisticMEHROTRA, Devan V; ROTH, Arthur J.Statistics in medicine. 2001, Vol 20, Num 14, pp 2099-2113, issn 0277-6715Article

Rank-Based Analyses of Stratified Experiments: Alternatives to the van Elteren TestMEHROTRA, Devan V; LU, Xiaomin; LI, Xiaoming et al.The American statistician. 2010, Vol 64, Num 2, pp 121-130, issn 0003-1305, 10 p.Article

Efficient and robust method for comparing the immunogenicity of candidate vaccines in randomized clinical trialsGILBERT, Peter B; SATO, Alicia; SUN, Xiao et al.Vaccine. 2009, Vol 27, Num 3, pp 396-401, issn 0264-410X, 6 p.Article

Eliciting a counterfactual sensitivity parameterSHEPHERD, Bryan E; GILBERT, Peter B; MEHROTRA, Devan V et al.The American statistician. 2007, Vol 61, Num 1, pp 56-63, issn 0003-1305, 8 p.Article

On power and sample size computation for multiple testing proceduresJIE CHEN; JIANFENG LUO; LIU, Kenneth et al.Computational statistics & data analysis. 2011, Vol 55, Num 1, pp 110-122, issn 0167-9473, 13 p.Article

Gatekeeping Testing via Adaptive Alpha AllocationJIANJUN LI; MEHROTRA, Devan V.Biometrical journal. 2008, Vol 50, Num 5, pp 704-715, issn 0323-3847, 12 p.Conference Paper

HIV Seroconversion without Infection after Receipt of Adenovirus-Vectored HIV Type 1 VaccineQUIRK, Erin K; MOGG, Robin; BROWN, Deborah D et al.Clinical infectious diseases. 2008, Vol 47, Num 12, pp 1593-1599, issn 1058-4838, 7 p.Article

Establishing efficacy of a new experimental treatment in the 'gold standard' design. DiscussionHAUSCHKE, Dieter; PIGEOT, Iris; LEWIS, John A et al.Biometrical journal. 2005, Vol 47, Num 6, pp 782-806, issn 0323-3847, 25 p.Article

Comparative Cell-Mediated Immunogenicity of DNA/DNA, DNA/Adenovirus Type 5 (Ad5), or Ad5/Ad5 HIV-1 Clade B gag Vaccine Prime-Boost RegimensASMUTH, David M; BROWN, Elizabeth L; CASIMIRO, Danilo R et al.The Journal of infectious diseases. 2010, Vol 201, Num 1, pp 132-141, issn 0022-1899, 10 p.Article

A comparison of standard immunogenicity assays for monitoring HIV type 1 gag-specific T cell responses in Ad5 HIV type 1 gag vaccinated human subjectsTOBERY, Timothy W; DUBEY, Sheri A; FU, Tong-Ming et al.AIDS research and human retroviruses. 2006, Vol 22, Num 11, pp 1081-1090, issn 0889-2229, 10 p.Article

Evaluation of cellular immune responses in subjects chronically infected with HIV type 1FU, Tong-Ming; DUBEY, Sheri A; GOEPFERT, Paul A et al.AIDS research and human retroviruses. 2007, Vol 23, Num 1, pp 67-76, issn 0889-2229, 10 p.Article

Comparison of T cell immune responses induced by vectored HIV vaccines in non-human primates and humansBETT, Andrew J; DUBEY, Sheri A; MESCHINO, Steve et al.Vaccine. 2010, Vol 28, Num 50, pp 7881-7889, issn 0264-410X, 9 p.Article

Safety and Immunogenicity of a Replication-Incompetent Adenovirus Type 5 HIV-1 Clade B gag/pol/nef Vaccine in Healthy AdultsPRIDDY, Frances H; BROWN, Deborah; BROWN, Stephen J et al.Clinical infectious diseases. 2008, Vol 46, Num 11, pp 1769-1781, issn 1058-4838, 13 p.Article

Impact of Herpes Simplex Virus Type 2 on HIV-1 Acquisition and Progression in an HIV Vaccine Trial (the Step Study)BARNABAS, Ruanne V; WASSERHEIT, Judith N; COREY, Lawrence et al.Journal of acquired immune deficiency syndromes (1999). 2011, Vol 57, Num 3, pp 238-244, issn 1525-4135, 7 p.Article

Safety and Immunogenicity of Adenovirus-Vectored Near-Consensus HIV Type 1 Clade B gag Vaccines in Healthy AdultsHARRO, Clayton D; ROBERTSON, Michael N; XIAO SUN et al.AIDS research and human retroviruses. 2009, Vol 25, Num 1, pp 103-114, issn 0889-2229, 12 p.Article

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study) : a double-blind, randomised, placebo-controlled, test-of-concept trial. CommentaryROBB, Merlin L; BUCHBINDER, Susan P; DEL RIO, Carlos et al.Lancet (British edition). 2008, Vol 372, Num 9653, issn 0140-6736, 1857-1858, 1881-1893 [15 p.]Article

Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continentsCOPLAN, Paul M; GUPTA, Swati B; FU, Tong-Ming et al.The Journal of infectious diseases. 2005, Vol 191, Num 9, pp 1427-1434, issn 0022-1899, 8 p.Article

Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy AdultsNICHOLSON, Ouzama; DICANDILO, Fay; SELF, Steven et al.AIDS research and human retroviruses. 2011, Vol 27, Num 5, pp 557-567, issn 0889-2229, 11 p.Article

HIV-1 vaccine-induced immunity in the test-of-concept Step Study : a case-cohort analysisMCELRATH, M. Juliana; DE ROSA, Stephen C; BUCHBINDER, Susan P et al.Lancet (British edition). 2008, Vol 372, Num 9653, pp 1894-1905, issn 0140-6736, 12 p.Article

Enhanced rates and magnitude of immune responses detected against an HIV vaccine : Effect of using an optimized process for isolating PBMCKIERSTEAD, Lisa S; DUBEY, Sheri; SYKES, Kara J et al.AIDS research and human retroviruses. 2007, Vol 23, Num 1, pp 86-92, issn 0889-2229, 7 p.Article

Estimating the benefit of an HIV-1 vaccine that reduces viral load set pointGUPTA, Swati B; JACOBSON, Lisa P; MARGOLICK, Joseph B et al.The Journal of infectious diseases. 2007, Vol 195, Num 4, pp 546-550, issn 0022-1899, 5 p.Article